Back to Menu
Brain metastasis, also termed intracranial metastatic tumor, refers to a secondary intracranial tumor formed when malignant cells originating from other organs or tissues disseminate to the cranial cavity via hematogenous spread, the lymphatic system, and other routes. Its incidence far exceeds that of primary brain tumors. The presence of brain metastasis indicates that the primary cancer has entered an advanced stage (stage IV) and represents a common clinical challenge in neuro-oncology.
1. Classification by number of metastatic lesions
Brain metastases are classified as solitary (single lesion) or multiple (two or more lesions). Solitary metastasis generally carries a better prognosis and may be amenable to definitive local therapy.
2. Classification by primary tumor origin
Common primary sources include lung cancer and breast cancer, and therapeutic responsiveness varies substantially by origin.
3. Classification by imaging features
Based on the extent of edema on MRI, metastases may be graded as mild, moderate, or severe, correlating with symptom severity and urgency of intervention.
4. Special type: leptomeningeal metastasis
Tumor cells disseminate widely within the meninges, often causing multiple cranial nerve deficits and hydrocephalus, with a poor prognosis.
1. Presence of a primary malignant tumor
A prerequisite for brain metastasis is the presence of an aggressive primary cancer (e.g., lung cancer, breast cancer) with a higher propensity for intracranial spread.
2. Tumor cell intravasation
After acquiring invasive capacity, primary tumor cells breach the basement membrane and enter the vascular system, gaining access to systemic circulation.
3. Survival and transport in the bloodstream
Circulating tumor cells must evade immune clearance and withstand shear stress while traveling through the circulation to the cerebral microvasculature.
4. Arrest in cerebral microvessels and extravasation
Tumor cells become trapped in brain microvessels and adhere to and traverse the blood–brain barrier through specific mechanisms to enter the brain parenchyma.
5. Adaptation to the brain microenvironment and proliferation
Disseminated cells must adapt to the unique brain microenvironment; successful colonization is followed by clonal expansion to form metastatic lesions.
1. Active treatment and control of the primary cancer
The most fundamental measure is standardized therapy for the primary tumor to control disease and reduce the risk of dissemination.
2. Regular neuroimaging surveillance for high-risk patients
High-risk patients with lung cancer, breast cancer, and related malignancies should undergo periodic brain MRI screening even in the absence of symptoms to detect small metastatic lesions.
3. Recognition of early neurological symptoms
Awareness of early warning signs such as new-onset headache and personality changes is important; prompt evaluation is warranted if symptoms develop.
4. Adverse-effect management and supportive care during treatment
Actively manage complications such as cerebral edema and seizures, maintain nutrition and appropriate exercise, and preserve functional status.
5. Neurocognitive rehabilitation and psychological support
Brain metastasis and its treatment can impair cognition; rehabilitation is recommended, and psychological support can help address anxiety and depression.
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that brain metastasis is a severe complication of advanced cancer that can damage brain tissue and cause life-threatening intracranial hypertension. Standardized MDT-based multimodal management is pivotal for disease control, prolonging survival, and improving quality of life. With advances in precision medicine, early diagnosis and systematic planning can provide patients with improved prognosis.
Brain metastasis, also termed intracranial metastatic tumor, refers to a secondary intracranial tumor formed when malignant cells originating from other organs or tissues disseminate to the cranial cavity via hematogenous spread, the lymphatic system, and other routes. Its incidence far exceeds that of primary brain tumors. The presence of brain metastasis indicates that the primary cancer has entered an advanced stage (stage IV) and represents a common clinical challenge in neuro-oncology.
1. Classification by number of metastatic lesions
Brain metastases are classified as solitary (single lesion) or multiple (two or more lesions). Solitary metastasis generally carries a better prognosis and may be amenable to definitive local therapy.
2. Classification by primary tumor origin
Common primary sources include lung cancer and breast cancer, and therapeutic responsiveness varies substantially by origin.
3. Classification by imaging features
Based on the extent of edema on MRI, metastases may be graded as mild, moderate, or severe, correlating with symptom severity and urgency of intervention.
4. Special type: leptomeningeal metastasis
Tumor cells disseminate widely within the meninges, often causing multiple cranial nerve deficits and hydrocephalus, with a poor prognosis.
1. Presence of a primary malignant tumor
A prerequisite for brain metastasis is the presence of an aggressive primary cancer (e.g., lung cancer, breast cancer) with a higher propensity for intracranial spread.
2. Tumor cell intravasation
After acquiring invasive capacity, primary tumor cells breach the basement membrane and enter the vascular system, gaining access to systemic circulation.
3. Survival and transport in the bloodstream
Circulating tumor cells must evade immune clearance and withstand shear stress while traveling through the circulation to the cerebral microvasculature.
4. Arrest in cerebral microvessels and extravasation
Tumor cells become trapped in brain microvessels and adhere to and traverse the blood–brain barrier through specific mechanisms to enter the brain parenchyma.
5. Adaptation to the brain microenvironment and proliferation
Disseminated cells must adapt to the unique brain microenvironment; successful colonization is followed by clonal expansion to form metastatic lesions.
1. Active treatment and control of the primary cancer
The most fundamental measure is standardized therapy for the primary tumor to control disease and reduce the risk of dissemination.
2. Regular neuroimaging surveillance for high-risk patients
High-risk patients with lung cancer, breast cancer, and related malignancies should undergo periodic brain MRI screening even in the absence of symptoms to detect small metastatic lesions.
3. Recognition of early neurological symptoms
Awareness of early warning signs such as new-onset headache and personality changes is important; prompt evaluation is warranted if symptoms develop.
4. Adverse-effect management and supportive care during treatment
Actively manage complications such as cerebral edema and seizures, maintain nutrition and appropriate exercise, and preserve functional status.
5. Neurocognitive rehabilitation and psychological support
Brain metastasis and its treatment can impair cognition; rehabilitation is recommended, and psychological support can help address anxiety and depression.
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that brain metastasis is a severe complication of advanced cancer that can damage brain tissue and cause life-threatening intracranial hypertension. Standardized MDT-based multimodal management is pivotal for disease control, prolonging survival, and improving quality of life. With advances in precision medicine, early diagnosis and systematic planning can provide patients with improved prognosis.